Biotech developing long-acting treatments for growth hormone deficiency.
Industry: Health Care
First Day Return: +49.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/18/2014 |
Offer Price | $21.00 |
Price Range $19.00 - $21.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $126 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/20/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $126 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Redwood City, CA, United States |
Founded | 2008 |
Employees at IPO | 14 |
Website www.versartis.com |